No immunity for £77m vaccine tax avoidance scheme

No immunity for £77m vaccine tax avoidance scheme

Scheme seeking to exploit research and development tax reliefs is shut down in upper-tier tribunal

A TAX AVOIDANCE SCHEME that sought to exploit reliefs put in place for the development of life-saving vaccines has been shut down in the upper-tier tribunal.

Investors in the scheme used a Jersey-registered limited partnership that claimed to be involved in creating and exploiting intellectual property from research into vaccines against diseases such as HIV, flu, hepatitis A and hepatitis B.

The Vaccine Research Limited Partnership scheme, promoted by Matrix Structured Finance, sought to exploit a tax relief for spending on research and development by claiming back all the tax due on an alleged investment of £114m and a first year trading loss of £193m.

In summing up, Justice Sales said: “The memorandum makes it clear that investors who invest in the partnership expect to receive a return based on tax relief on a proportion of the total sum described as paid by the partnership to numology, namely £193m.

“The FTT found that it was not severable. This was a view which it was plainly entitled to take on the evidence. Indeed, we think it would have been difficult for any other view to be taken. The FTT found that the Partnership engaged in both trade and non-trade activities and that the Matrix fee was attributable to both. Therefore, the ‘wholly and exclusively’ test could not be satisfied by the partnership. We consider that this conclusion is unassailable.”

David Gauke, financial secretary to the Treasury, added: “This is the latest in a series of HMRC tribunal wins over avoidance schemes whose members try to exploit the rules for partnerships rather than accept their responsibilities as taxpayers.”

Whitepaper

The Future of Finance is in the CFO's Hands

Business The Future of Finance is in the CFO's Hands

2m
Save a Week a Month Consolidating Accounts

Accounting Software Save a Week a Month Consolidating Accounts

3m
Mitigating Risk Through Internal Control

Legal Mitigating Risk Through Internal Control

4m
Could tax season have run more efficiently?

Corporate Tax Could tax season have run more efficiently?

4m

Related Articles

R&D tax relief claims are rising, HMRC report reveals

Corporate Tax R&D tax relief claims are rising, HMRC report reveals

9m Emanuela Hawker, Reporter
Appropriate tax systems – taxation in the ‘Fourth Industrial Revolution’

Corporate Tax Appropriate tax systems – taxation in the ‘Fourth Industrial Revolution’

10m Jane Mackay, Crowe
Watch out when winding up

Corporate Tax Watch out when winding up

1y Emma Rawson, ATT Technical Officer
HMRC large business tax enquiry duration rises to 3 years

Corporate Tax HMRC large business tax enquiry duration rises to 3 years

1y Emma Smith, Managing Editor
Big names, little tax: Airbnb, Facebook, Kellogg’s, eBay

Corporate Tax Big names, little tax: Airbnb, Facebook, Kellogg’s, eBay

2y Alia Shoaib, Reporter
EU divided over radical tax reforms targeting tech giants

Corporate Tax EU divided over radical tax reforms targeting tech giants

2y Alia Shoaib, Reporter
How to educate your clients about tax avoidance

Corporate Tax How to educate your clients about tax avoidance

2y Clear Books | Sponsored
CGT clampdown nets HMRC £124m – but could lead to increase in use of avoidance schemes

Corporate Tax CGT clampdown nets HMRC £124m – but could lead to increase in use of avoidance schemes

2y Austin Clark, Reporter